Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Alzheimer's Disease

  Free Subscription


Articles published in Brain

Retrieve available abstracts of 147 articles:
HTML format



Single Articles


    June 2022
  1. KAIVOLA K, Shah Z, Chia R, Scholz SW, et al
    Genetic evaluation of dementia with Lewy bodies implicates distinct disease subgroups.
    Brain. 2022;145:1757-1762.
    PubMed     Abstract available


    May 2022
  2. TONIOLO S
    What plasma biomarkers tell us about hippocampal microstructural changes in Alzheimer's disease.
    Brain. 2022 May 25. pii: 6591892. doi: 10.1093.
    PubMed    


  3. DUZEL E, Ziegler G, Berron D, Maass A, et al
    Amyloid pathology but not APOE epsilon4 status is permissive for tau-related hippocampal dysfunction.
    Brain. 2022;145:1473-1485.
    PubMed     Abstract available


  4. KO H, Kim S, Kim K, Jung SH, et al
    Genome-wide association study of occupational attainment as a proxy for cognitive reserve.
    Brain. 2022;145:1436-1448.
    PubMed     Abstract available


  5. MORRIS JC, Weiner M, Xiong C, Beckett L, et al
    Autosomal dominant and sporadic late onset Alzheimer disease share a common in vivo pathophysiology.
    Brain. 2022 May 17. pii: 6587090. doi: 10.1093.
    PubMed     Abstract available


  6. MORRISON MS, Aparicio HJ, Blennow K, Zetterberg H, et al
    Antemortem plasma phosphorylated tau (181) predicts Alzheimer's disease neuropathology and regional tau at autopsy.
    Brain. 2022 May 13. pii: 6585495. doi: 10.1093.
    PubMed     Abstract available



  7. Correction to: Brain amyloid-beta oligomers in ageing and Alzheimer's disease.
    Brain. 2022 May 13. pii: 6585189. doi: 10.1093.
    PubMed    


  8. EISSMAN JM, Dumitrescu L, Mahoney ER, Smith AN, et al
    Sex differences in the genetic architecture of cognitive resilience to Alzheimer's disease.
    Brain. 2022 May 13. pii: 6585174. doi: 10.1093.
    PubMed     Abstract available


  9. ZHU WM, Neuhaus A, Beard DJ, Sutherland BA, et al
    Neurovascular coupling mechanisms in health and neurovascular uncoupling in Alzheimer's disease.
    Brain. 2022 May 13. pii: 6585171. doi: 10.1093.
    PubMed     Abstract available


  10. VROMEN EM, de Boer SCM, Teunissen CE, Rozemuller A, et al
    Biomarker A+T-: is this Alzheimer's disease or not? A combined CSF and pathology study.
    Brain. 2022 May 2. pii: 6576655. doi: 10.1093.
    PubMed     Abstract available


    April 2022
  11. BARKER MS, Gottesman RT, Manoochehri M, Chapman S, et al
    Proposed research criteria for prodromal behavioural variant frontotemporal dementia.
    Brain. 2022;145:1079-1097.
    PubMed     Abstract available


  12. LEGAZ A, Abrevaya S, Dottori M, Gonzalez Campo C, et al
    Multimodal mechanisms of human socially reinforced learning across neurodegenerative diseases.
    Brain. 2022;145:1052-1068.
    PubMed     Abstract available


  13. SHAHID SS, Wen Q, Risacher SL, Farlow MR, et al
    Hippocampal-subfield microstructures and their relation to plasma biomarkers in Alzheimer's disease.
    Brain. 2022 Apr 12. pii: 6566798. doi: 10.1093.
    PubMed     Abstract available


  14. OLIVEROS G, Wallace CH, Chaudry O, Liu Q, et al
    Repurposing ibudilast to mitigate Alzheimer's disease by targeting inflammation.
    Brain. 2022 Apr 12. pii: 6566790. doi: 10.1093.
    PubMed     Abstract available


  15. STEVENSON-HOARE J, Heslegrave A, Leonenko G, Fathalla D, et al
    Plasma biomarkers and genetics in the diagnosis and prediction of Alzheimer's disease.
    Brain. 2022 Apr 6. pii: 6564132. doi: 10.1093.
    PubMed     Abstract available


  16. PADHI S, Sarangi S, Nayak N, Pati A, et al
    OAS1 rs1131454 genetic variant is associated with Alzheimer's disease: an epidemiological analysis.
    Brain. 2022 Apr 6. pii: 6564066. doi: 10.1093.
    PubMed    


    March 2022
  17. JEONG YY, Han S, Jia N, Zhang M, et al
    Broad activation of the Parkin pathway induces synaptic mitochondrial deficits in early tauopathy.
    Brain. 2022;145:305-323.
    PubMed     Abstract available


  18. BENATAR M, Wuu J, McHutchison C, Postuma RB, et al
    Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases.
    Brain. 2022;145:27-44.
    PubMed     Abstract available


  19. HOSOKAWA M, Masuda-Suzukake M, Shitara H, Shimozawa A, et al
    Development of a novel tau propagation mouse model endogenously expressing 3 and 4 repeat tau isoforms.
    Brain. 2022;145:349-361.
    PubMed     Abstract available


  20. GIACOBINI E, Cuello AC, Fisher A
    Reimagining cholinergic therapy for Alzheimer's disease.
    Brain. 2022 Mar 15. pii: 6548684. doi: 10.1093.
    PubMed     Abstract available


  21. SHETTY AK
    Can rapamycin slow down memory decline in Alzheimer's disease with seizures?
    Brain. 2022 Mar 12. pii: 6547363. doi: 10.1093.
    PubMed    


  22. LAM AD, Shafi MM
    Towards a coherent view of network hyperexcitability in Alzheimer's disease.
    Brain. 2022 Mar 8. pii: 6544859. doi: 10.1093.
    PubMed    


  23. LIN CP, Frigerio I, Boon BDC, Zhou Z, et al
    Structural (dys)connectivity associates with cholinergic cell density in Alzheimer's disease.
    Brain. 2022 Mar 8. pii: 6543231. doi: 10.1093.
    PubMed     Abstract available


  24. GABRIELLI M, Prada I, Joshi P, Falcicchia C, et al
    Microglial large extracellular vesicles propagate early synaptic dysfunction in Alzheimer's disease.
    Brain. 2022 Mar 3. pii: 6541881. doi: 10.1093.
    PubMed     Abstract available


    February 2022
  25. BEAMAN EE, Bonde AN, Ulv Larsen SM, Ozenne B, et al
    Blood-brain barrier permeable beta-blockers linked to lower risk of Alzheimer's disease in hypertension.
    Brain. 2022 Feb 23. pii: 6535129. doi: 10.1093.
    PubMed     Abstract available


  26. PERIS L, Parato J, Qu X, Soleilhac JM, et al
    Tubulin tyrosination regulates synaptic function and is disrupted in Alzheimer's disease.
    Brain. 2022 Feb 11. pii: 6527175. doi: 10.1093.
    PubMed     Abstract available


    January 2022
  27. KARANTH SD, Katsumata Y, Nelson PT, Fardo DW, et al
    Cancer diagnosis is associated with a lower burden of dementia and less Alzheimer's-type neuropathology.
    Brain. 2022 Jan 30. pii: 6517521. doi: 10.1093.
    PubMed     Abstract available


  28. WIESMAN AI, Murman DL, Losh RA, Schantell M, et al
    Spatially resolved neural slowing predicts impairment and amyloid burden in Alzheimer's disease.
    Brain. 2022 Jan 28. pii: 6516524. doi: 10.1093.
    PubMed     Abstract available


  29. MARTINO ADAMI PV, Orellana A, Garcia P, Kleineidam L, et al
    Matrix metalloproteinase 10 is linked to the risk of progression to dementia of the Alzheimer's type.
    Brain. 2022 Jan 28. pii: 6516341. doi: 10.1093.
    PubMed     Abstract available


  30. STERN AM, Liu L, Jin S, Liu W, et al
    A calcium-sensitive antibody isolates soluble amyloid-beta aggregates and fibrils from Alzheimer's disease brain.
    Brain. 2022 Jan 27. pii: 6516009. doi: 10.1093.
    PubMed     Abstract available


  31. ALI M, Falkenhain K, Njiru BN, Murtaza-Ali M, et al
    VEGF signalling causes stalls in brain capillaries and reduces cerebral blood flow in Alzheimer's mice.
    Brain. 2022 Jan 20. pii: 6512043. doi: 10.1093.
    PubMed     Abstract available


  32. BRIDEL C, Somers C, Sieben A, Rozemuller A, et al
    Associating Alzheimer's disease pathology with its cerebrospinal fluid biomarkers.
    Brain. 2022 Jan 13. pii: 6506576. doi: 10.1093.
    PubMed     Abstract available


    December 2021
  33. RANASINGHE KG, Kudo K, Hinkley L, Beagle A, et al
    Neuronal synchrony abnormalities associated with subclinical epileptiform activity in early onset Alzheimer's disease.
    Brain. 2021 Dec 17. pii: 6469013. doi: 10.1093.
    PubMed     Abstract available


  34. XHIMA K, Markham-Coultes K, Kofoed RH, Saragovi HU, et al
    Ultrasound delivery of a TrkA agonist confers neuroprotection to Alzheimer-associated pathologies.
    Brain. 2021 Dec 17. pii: 6469023. doi: 10.1093.
    PubMed     Abstract available


  35. TSAI HH, Chen YF, Yen RF, Lo YL, et al
    Plasma soluble TREM2 is associated with white matter lesions independent of amyloid and tau.
    Brain. 2021;144:3371-3380.
    PubMed     Abstract available


  36. PASCOAL TA, Benedet AL, Tudorascu DL, Therriault J, et al
    Longitudinal 18F-MK-6240 tau tangles accumulation follows Braak stages.
    Brain. 2021;144:3517-3528.
    PubMed     Abstract available


    November 2021
  37. VERDI S, Marquand AF, Schott JM, Cole JH, et al
    Beyond the average patient: how neuroimaging models can address heterogeneity in dementia.
    Brain. 2021;144:2946-2953.
    PubMed     Abstract available


    October 2021
  38. ZHANG Y, Zhang Y, Aman Y, Ng CT, et al
    Amyloid-beta toxicity modulates tau phosphorylation through the PAX6 signalling pathway.
    Brain. 2021;144:2759-2770.
    PubMed     Abstract available


  39. LUCEY BP, Wisch J, Boerwinkle AH, Landsness EC, et al
    Sleep and longitudinal cognitive performance in preclinical and early symptomatic Alzheimer's disease.
    Brain. 2021 Oct 20. pii: 6401973. doi: 10.1093.
    PubMed     Abstract available


  40. LEVY JP, Bezgin G, Savard M, Pascoal TA, et al
    18F-MK-6240 tau-PET in genetic frontotemporal dementia.
    Brain. 2021 Oct 19. pii: 6402002. doi: 10.1093.
    PubMed     Abstract available


  41. MAGUSALI N, Graham AC, Piers TM, Panichnantakul P, et al
    A genetic link between risk for Alzheimer's disease and severe COVID-19 outcomes via the OAS1 gene.
    Brain. 2021 Oct 7. pii: 6382473. doi: 10.1093.
    PubMed     Abstract available


  42. KHAN AF, Adewale Q, Baumeister TR, Carbonell F, et al
    Personalized brain models identify neurotransmitter receptor changes in Alzheimer's disease.
    Brain. 2021 Oct 4. pii: 6380944. doi: 10.1093.
    PubMed     Abstract available


  43. SCHUMACHER J, Ray NJ, Hamilton CA, Donaghy PC, et al
    Cholinergic white matter pathways in dementia with Lewy bodies and Alzheimer's disease.
    Brain. 2021 Oct 4. pii: 6380941. doi: 10.1093.
    PubMed     Abstract available


    September 2021

  44. Erratum to: Cardiovascular brain impulses in Alzheimer's disease.
    Brain. 2021 Sep 22. pii: 6373794. doi: 10.1093.
    PubMed    


  45. STOTHART G, Smith LJ, Milton A, Coulthard E, et al
    A passive and objective measure of recognition memory in Alzheimer's disease using Fastball memory assessment.
    Brain. 2021 Sep 20. pii: 6372384. doi: 10.1093.
    PubMed     Abstract available


    August 2021
  46. KHAN AR, Ottoy J, Goubran M
    Towards a comprehensive 3D mapping of tau progression in early Alzheimer's disease.
    Brain. 2021 Aug 23. pii: 6356553. doi: 10.1093.
    PubMed    


  47. DAVILA-BOUZIGUET E, Casoliba-Melich A, Targa-Fabra G, Galera-Lopez L, et al
    Functional protection in J20/VLW mice: a model of non-demented with Alzheimer's disease neuropathology.
    Brain. 2021 Aug 23. pii: 6356505. doi: 10.1093.
    PubMed     Abstract available


  48. BOYLE PA, Wang T, Yu L, Wilson RS, et al
    To what degree is late life cognitive decline driven by age-related neuropathologies?
    Brain. 2021;144:2166-2175.
    PubMed     Abstract available


  49. HOLLAND N, Malpetti M, Rittman T, Mak EE, et al
    Molecular pathology and synaptic loss in primary tauopathies: an 18F-AV-1451 and 11C-UCB-J PET study.
    Brain. 2021 Aug 16. pii: 6353021. doi: 10.1093.
    PubMed     Abstract available


  50. STROM A, Iaccarino L, Edwards L, Lesman-Segev OH, et al
    Cortical hypometabolism reflects local atrophy and tau pathology in symptomatic Alzheimer's disease.
    Brain. 2021 Aug 9. pii: 6346980. doi: 10.1093.
    PubMed     Abstract available


    July 2021
  51. PAUMIER A, Boisseau S, Jacquier-Sarlin M, Pernet-Gallay K, et al
    Astrocyte-neuron interplay is critical for Alzheimer's disease pathogenesis and is rescued by TRPA1 channel blockade.
    Brain. 2021 Jul 24. pii: 6327685. doi: 10.1093.
    PubMed     Abstract available


  52. GOURMAUD S, Stewart DA, Irwin DJ, Roberts N, et al
    The role of mTORC1 activation in seizure-induced exacerbation of Alzheimer's disease.
    Brain. 2021 Jul 15. pii: 6321945. doi: 10.1093.
    PubMed     Abstract available


  53. BERRON D, van Westen D, Ossenkoppele R, Strandberg O, et al
    Corrigendum to: Medial temporal lobe connectivity and its associations with cognition in early Alzheimer's disease.
    Brain. 2021 Jul 14. pii: 6321152. doi: 10.1093.
    PubMed    


  54. PEREIRA JB, Janelidze S, Smith R, Mattsson-Carlgren N, et al
    Plasma GFAP is an early marker of amyloid-beta but not tau pathology in Alzheimer's disease.
    Brain. 2021 Jul 14. pii: 6321226. doi: 10.1093.
    PubMed     Abstract available


  55. BAILES SM, Lewis LD
    Distinct cardiac-locked brain pulsations in Alzheimer's disease.
    Brain. 2021 Jul 9. pii: 6318392. doi: 10.1093.
    PubMed    


  56. HORIE K, Barthelemy NR, Sato C, Bateman RJ, et al
    Corrigendum to: CSF tau microtubule binding region identifies tau tangle and clinical stages of Alzheimer's disease.
    Brain. 2021 Jul 3. pii: 6313379. doi: 10.1093.
    PubMed    


    June 2021
  57. RIES M, Watts H, Mota BC, Lopez MY, et al
    Annexin A1 restores cerebrovascular integrity concomitant with reduced amyloid-beta and tau pathology.
    Brain. 2021;144:1526-1541.
    PubMed     Abstract available


  58. MATTHEWS DC, Mao X, Dowd K, Tsakanikas D, et al
    Riluzole, a glutamate modulator, slows cerebral glucose metabolism decline in patients with Alzheimer's disease.
    Brain. 2021 Jun 18. pii: 6305835. doi: 10.1093.
    PubMed     Abstract available


  59. PATEL AG, Nehete PN, Krivoshik SR, Pei X, et al
    Innate immunity stimulation via CpG oligodeoxynucleotides ameliorates Alzheimer's disease pathology in aged squirrel monkeys.
    Brain. 2021 Jun 15. pii: 6297373. doi: 10.1093.
    PubMed     Abstract available


  60. SCHUMACHER J, Gunter JL, Przybelski SA, Jones DT, et al
    Dementia with Lewy bodies: association of Alzheimer pathology with functional connectivity networks.
    Brain. 2021 Jun 11. pii: 6296589. doi: 10.1093.
    PubMed     Abstract available


    May 2021

  61. Erratum to: The development and convergence of co-pathologies in Alzheimer's disease.
    Brain. 2021 May 23. pii: 6282423. doi: 10.1093.
    PubMed    


  62. DEHGHANI N, Bras J, Guerreiro R
    Erratum to: How understudied populations have contributed to our understanding of Alzheimer's disease genetics.
    Brain. 2021 May 20. pii: 6279241. doi: 10.1093.
    PubMed    


    April 2021
  63. O'CONNOR A, Pannee J, Poole T, Arber C, et al
    Plasma amyloid-beta ratios in autosomal dominant Alzheimer's disease: the influence of genotype.
    Brain. 2021 Apr 23. pii: 6248083. doi: 10.1093.
    PubMed     Abstract available


  64. DEHGHANI N, Bras J, Guerreiro R
    How understudied populations have contributed to our understanding of Alzheimer's disease genetics.
    Brain. 2021 Apr 23. pii: 6247156. doi: 10.1093.
    PubMed     Abstract available


  65. YAO Y, Kang SS, Xia Y, Wang ZH, et al
    A delta-secretase-truncated APP fragment activates CEBPB, mediating Alzheimer's disease pathologies.
    Brain. 2021 Apr 20. pii: 6242262. doi: 10.1093.
    PubMed     Abstract available



  66. Erratum to: Time course of phosphorylated-tau181 in blood across the Alzheimer's disease spectrum.
    Brain. 2021 Apr 20. pii: 6238673. doi: 10.1093.
    PubMed    


  67. OZAWA S, Hori Y, Shimizu Y, Taniguchi A, et al
    Photo-oxygenation by a biocompatible catalyst reduces amyloid-beta levels in Alzheimer's disease mice.
    Brain. 2021 Apr 14. pii: 6224831. doi: 10.1093.
    PubMed     Abstract available


  68. TOME SO, Thal DR
    Co-pathologies in Alzheimer's disease: just multiple pathologies or partners in crime?
    Brain. 2021;144:706-708.
    PubMed    



  69. Corrigendum to: Monitoring the progression of Alzheimer's disease with tau-PET.
    Brain. 2021 Apr 6. pii: 6213355. doi: 10.1093.
    PubMed    


    March 2021
  70. RAJNA Z, Mattila H, Huotari N, Tuovinen T, et al
    Cardiovascular brain impulses in Alzheimer's disease.
    Brain. 2021 Mar 31. pii: 6206368. doi: 10.1093.
    PubMed     Abstract available


  71. YAP SY, Frias B, Wren MC, Scholl M, et al
    Discriminatory ability of next-generation tau PET tracers for Alzheimer's disease.
    Brain. 2021 Mar 20. pii: 6179104. doi: 10.1093.
    PubMed     Abstract available


  72. EWERS M, Luan Y, Frontzkowski L, Neitzel J, et al
    Segregation of functional networks is associated with cognitive resilience in Alzheimer's disease.
    Brain. 2021 Mar 16. pii: 6174116. doi: 10.1093.
    PubMed     Abstract available


  73. ASBY D, Boche D, Allan S, Love S, et al
    Systemic infection exacerbates cerebrovascular dysfunction in Alzheimer's disease.
    Brain. 2021 Mar 16. pii: 6173392. doi: 10.1093.
    PubMed     Abstract available


  74. SPINA S, La Joie R, Petersen C, Nolan AL, et al
    Comorbid neuropathological diagnoses in early versus late-onset Alzheimer's disease.
    Brain. 2021 Mar 9. pii: 6164966. doi: 10.1093.
    PubMed     Abstract available


  75. HUSAIN M
    Blood tests to screen for Alzheimer's disease.
    Brain. 2021;144:355-356.
    PubMed    


  76. KIM JH, Afridi R, Han J, Jung HG, et al
    Gamma subunit of complement component 8 is a neuroinflammation inhibitor.
    Brain. 2021;144:528-552.
    PubMed     Abstract available


    February 2021
  77. JAGUST W
    Integrating events in the disintegration of Alzheimer's disease.
    Brain. 2021;144:11-14.
    PubMed    


  78. TIJMS BM, Teunissen CE
    Concatenating plasma p-tau to Alzheimer's disease.
    Brain. 2021;144:14-17.
    PubMed    


    January 2021
  79. KESHAVAN A, Pannee J, Karikari TK, Rodriguez JL, et al
    Population-based blood screening for preclinical Alzheimer's disease in a British birth cohort at age 70.
    Brain. 2021 Jan 22. pii: 6105867. doi: 10.1093.
    PubMed     Abstract available



  80. Erratum to: Alzheimer's disease brain-derived extracellular vesicles spread tau pathology in interneurons.
    Brain. 2021 Jan 12. pii: 6091150. doi: 10.1093.
    PubMed    


    December 2020
  81. JOHNSON JCS, Marshall CR, Weil RS, Bamiou DE, et al
    Hearing and dementia: from ears to brain.
    Brain. 2020 Dec 22. pii: 6044086. doi: 10.1093.
    PubMed     Abstract available


  82. MONTERO-CRESPO M, Dominguez-Alvaro M, Alonso-Nanclares L, DeFelipe J, et al
    Three-dimensional analysis of synaptic organization in the hippocampal CA1 field in Alzheimer's disease.
    Brain. 2020 Dec 16. pii: 6038920. doi: 10.1093.
    PubMed     Abstract available


  83. HORIE K, Barthelemy NR, Sato C, Bateman RJ, et al
    CSF tau microtubule binding region identifies tau tangle and clinical stages of Alzheimer's disease.
    Brain. 2020 Dec 7. pii: 6024973. doi: 10.1093.
    PubMed     Abstract available


  84. TEUNISSEN CE, Thijssen EH, Verberk IMW
    Plasma p-tau217: from 'new kid' to most promising candidate for Alzheimer's disease blood test.
    Brain. 2020;143:3170-3172.
    PubMed    


  85. PEREIRA JB, Janelidze S, Ossenkoppele R, Kvartsberg H, et al
    Untangling the association of amyloid-beta and tau with synaptic and axonal loss in Alzheimer's disease.
    Brain. 2020 Dec 5. pii: 6024803. doi: 10.1093.
    PubMed     Abstract available


  86. TIJMS BM, Gobom J, Reus L, Jansen I, et al
    Pathophysiological subtypes of Alzheimer's disease based on cerebrospinal fluid proteomics.
    Brain. 2020;143:3776-3792.
    PubMed     Abstract available


  87. SMITH R, Strandberg O, Mattsson-Carlgren N, Leuzy A, et al
    The accumulation rate of tau aggregates is higher in females and younger amyloid-positive subjects.
    Brain. 2020;143:3805-3815.
    PubMed     Abstract available


  88. FLORES-AGUILAR L, Iulita MF, Kovecses O, Torres MD, et al
    Evolution of neuroinflammation across the lifespan of individuals with Down syndrome.
    Brain. 2020;143:3653-3671.
    PubMed     Abstract available


    November 2020
  89. MOSCOSO A, Grothe MJ, Ashton NJ, Karikari TK, et al
    Time course of phosphorylated-tau181 in blood across the Alzheimer's disease spectrum.
    Brain. 2020 Nov 30. pii: 6012955. doi: 10.1093.
    PubMed     Abstract available


  90. BRIER MR, Day GS
    Serum neurofilament light chain uncovers neurodegeneration early in the course of Alzheimer's disease.
    Brain. 2020 Nov 30. pii: 6012788. doi: 10.1093.
    PubMed    


  91. SUR C, Kost J, Scott D, Adamczuk K, et al
    BACE inhibition causes rapid, regional, and non-progressive volume reduction in Alzheimer's disease brain.
    Brain. 2020 Nov 30. pii: 6012787. doi: 10.1093.
    PubMed     Abstract available


  92. RUAN Z, Pathak D, Venkatesan Kalavai S, Yoshii-Kitahara A, et al
    Alzheimer's disease brain-derived extracellular vesicles spread tau pathology in interneurons.
    Brain. 2020 Nov 27. pii: 6007752. doi: 10.1093.
    PubMed     Abstract available


  93. BENEDET AL, Leuzy A, Pascoal TA, Ashton NJ, et al
    Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease.
    Brain. 2020 Nov 19. pii: 5990278. doi: 10.1093.
    PubMed     Abstract available


  94. JIA L, Li F, Wei C, Zhu M, et al
    Prediction of Alzheimer's disease using multi-variants from a Chinese genome-wide association study.
    Brain. 2020 Nov 14. pii: 5981992. doi: 10.1093.
    PubMed     Abstract available


  95. LIU KY, Reeves S, McAleese KE, Attems J, et al
    Neuropsychiatric symptoms in limbic-predominant age-related TDP-43 encephalopathy and Alzheimer's disease.
    Brain. 2020 Nov 14. pii: 5981742. doi: 10.1093.
    PubMed     Abstract available


  96. JI X, Liu G
    rs34331204 regulates TSPAN13 expression and contributes to Alzheimer's disease with sex differences.
    Brain. 2020 Nov 11. pii: 5974904. doi: 10.1093.
    PubMed    


  97. DUMITRESCU L, Hohman TJ
    Reply: rs34331204 regulates TSPAN13 expression and contributes to Alzheimer's disease with sex differences.
    Brain. 2020 Nov 11. pii: 5974883. doi: 10.1093.
    PubMed    


  98. JOSEPHS KA, Martin PR, Weigand SD, Tosakulwong N, et al
    Protein contributions to brain atrophy acceleration in Alzheimer's disease and primary age-related tauopathy.
    Brain. 2020 Nov 5. pii: 5956321. doi: 10.1093.
    PubMed     Abstract available


  99. SOLEIMANI-MEIGOONI DN, Iaccarino L, La Joie R, Baker S, et al
    18F-flortaucipir PET to autopsy comparisons in Alzheimer's disease and other neurodegenerative diseases.
    Brain. 2020 Nov 3. pii: 5952719. doi: 10.1093.
    PubMed     Abstract available


    October 2020
  100. MATTSSON-CARLGREN N, Janelidze S, Palmqvist S, Cullen N, et al
    Longitudinal plasma p-tau217 is increased in early stages of Alzheimer's disease.
    Brain. 2020 Oct 17. pii: 5929275. doi: 10.1093.
    PubMed     Abstract available


    September 2020
  101. FORSBERG MOREN A, Varrone A
    Timing is everything: tau imaging across stages of Alzheimer's disease.
    Brain. 2020;143:2634-2636.
    PubMed    


  102. HARDY CJD, Yong KXX, Goll JC, Crutch SJ, et al
    Impairments of auditory scene analysis in posterior cortical atrophy.
    Brain. 2020 Sep 1. pii: 5900355. doi: 10.1093.
    PubMed     Abstract available


    August 2020
  103. HORSAGER J, Andersen KB, Knudsen K, Skjaerbaek C, et al
    Brain-first versus body-first Parkinson's disease: a multimodal imaging case-control study.
    Brain. 2020 Aug 24. pii: 5896254. doi: 10.1093.
    PubMed     Abstract available


  104. DRUMMOND E, Pires G, MacMurray C, Askenazi M, et al
    Phosphorylated tau interactome in the human Alzheimer's disease brain.
    Brain. 2020 Aug 19. pii: 5893817. doi: 10.1093.
    PubMed     Abstract available


  105. DUMITRESCU L, Mahoney ER, Mukherjee S, Lee ML, et al
    Genetic variants and functional pathways associated with resilience to Alzheimer's disease.
    Brain. 2020;143:2561-2575.
    PubMed     Abstract available


    July 2020
  106. HARRISON IF, Ismail O, Machhada A, Colgan N, et al
    Impaired glymphatic function and clearance of tau in an Alzheimer's disease model.
    Brain. 2020 Jul 23. pii: 5875735. doi: 10.1093.
    PubMed     Abstract available


  107. PASCOAL TA, Therriault J, Benedet AL, Savard M, et al
    18F-MK-6240 PET for early and late detection of neurofibrillary tangles.
    Brain. 2020 Jul 16. pii: 5872095. doi: 10.1093.
    PubMed     Abstract available


  108. COUSINS KAQ, Irwin DJ, Wolk DA, Lee EB, et al
    ATN status in amnestic and non-amnestic Alzheimer's disease and frontotemporal lobar degeneration.
    Brain. 2020;143:2295-2311.
    PubMed     Abstract available


    June 2020
  109. FAN CC, Banks SJ, Thompson WK, Chen CH, et al
    Sex-dependent autosomal effects on clinical progression of Alzheimer's disease.
    Brain. 2020 Jun 27. pii: 5863662. doi: 10.1093.
    PubMed     Abstract available


  110. SINTINI I, Graff-Radford J, Senjem ML, Schwarz CG, et al
    Longitudinal neuroimaging biomarkers differ across Alzheimer's disease phenotypes.
    Brain. 2020 Jun 23. pii: 5861030. doi: 10.1093.
    PubMed     Abstract available


  111. PRZYBYLA M, van Eersel J, van Hummel A, van der Hoven J, et al
    Onset of hippocampal network aberration and memory deficits in P301S tau mice are associated with an early gene signature.
    Brain. 2020;143:1889-1904.
    PubMed     Abstract available


    May 2020
  112. ARENA JD, Smith DH, Lee EB, Gibbons GS, et al
    Tau immunophenotypes in chronic traumatic encephalopathy recapitulate those of ageing and Alzheimer's disease.
    Brain. 2020 May 11. pii: 5835545. doi: 10.1093.
    PubMed     Abstract available


  113. MALPETTI M, Kievit RA, Passamonti L, Jones PS, et al
    Microglial activation and tau burden predict cognitive decline in Alzheimer's disease.
    Brain. 2020 May 7. pii: 5831943. doi: 10.1093.
    PubMed     Abstract available


  114. QIU S, Joshi PS, Miller MI, Xue C, et al
    Development and validation of an interpretable deep learning framework for Alzheimer's disease classification.
    Brain. 2020 May 1. pii: 5827821. doi: 10.1093.
    PubMed     Abstract available


    April 2020
  115. SPOTORNO N, Acosta-Cabronero J, Stomrud E, Lampinen B, et al
    Relationship between cortical iron and tau aggregation in Alzheimer's disease.
    Brain. 2020 Apr 24. pii: 5824902. doi: 10.1093.
    PubMed     Abstract available


  116. BERRON D, van Westen D, Ossenkoppele R, Strandberg O, et al
    Medial temporal lobe connectivity and its associations with cognition in early Alzheimer's disease.
    Brain. 2020 Apr 6. pii: 5816707. doi: 10.1093.
    PubMed     Abstract available


  117. VELDSMAN M
    Atrophy network mapping of transdiagnostic cognitive and neuropsychiatric symptoms.
    Brain. 2020;143:1053-1056.
    PubMed    


  118. DE WOLF F, Ghanbari M, Licher S, McRae-McKee K, et al
    Plasma tau, neurofilament light chain and amyloid-beta levels and risk of dementia; a population-based cohort study.
    Brain. 2020;143:1220-1232.
    PubMed     Abstract available


    March 2020
  119. TETREAULT AM, Phan T, Orlando D, Lyu I, et al
    Network localization of clinical, cognitive, and neuropsychiatric symptoms in Alzheimer's disease.
    Brain. 2020 Mar 16. pii: 5807900. doi: 10.1093.
    PubMed     Abstract available


  120. FERNANDEZ-CABELLO S, Kronbichler M, Van Dijk KRA, Goodman JA, et al
    Basal forebrain volume reliably predicts the cortical spread of Alzheimer's degeneration.
    Brain. 2020;143:993-1009.
    PubMed     Abstract available


  121. AGOSTA F, Canu E, Filippi M
    Virtual reality and real-time neurofeedback functional MRI: a breakthrough in foreseeing Alzheimer's disease?
    Brain. 2020;143:722-726.
    PubMed    


  122. SKOURAS S, Torner J, Andersson P, Koush Y, et al
    Earliest amyloid and tau deposition modulate the influence of limbic networks during closed-loop hippocampal downregulation.
    Brain. 2020;143:976-992.
    PubMed     Abstract available


    February 2020
  123. NELSON PT
    Reply: Selected cryptic exons accumulate in hippocampal cell nuclei in Alzheimer's disease with and without associated TDP-43 proteinopathy.
    Brain. 2020 Feb 4. pii: 5722221. doi: 10.1093.
    PubMed    


  124. TORRES P, Andres-Benito P, Fernandez-Bernal A, Ricart M, et al
    Selected cryptic exons accumulate in hippocampal cell nuclei in Alzheimer's disease with and without associated TDP-43 proteinopathy.
    Brain. 2020 Feb 4. pii: 5722222. doi: 10.1093.
    PubMed    


  125. PICHET BINETTE A, Gonneaud J, Vogel JW, La Joie R, et al
    Morphometric network differences in ageing versus Alzheimer's disease dementia.
    Brain. 2020;143:635-649.
    PubMed     Abstract available


  126. ITURRIA-MEDINA Y, Khan AF, Adewale Q, Shirazi AH, et al
    Blood and brain gene expression trajectories mirror neuropathology and clinical deterioration in neurodegeneration.
    Brain. 2020;143:661-673.
    PubMed     Abstract available


  127. TEYLAN M, Mock C, Gauthreaux K, Chen YC, et al
    Cognitive trajectory in mild cognitive impairment due to primary age-related tauopathy.
    Brain. 2020;143:611-621.
    PubMed     Abstract available


    January 2020
  128. ROBINSON JL, Richardson H, Xie SX, Suh E, et al
    The development and convergence of co-pathologies in Alzheimer's disease.
    Brain. 2020 Jan 15. pii: 6101614. doi: 10.1093.
    PubMed     Abstract available


  129. BETTHAUSER TJ, Koscik RL, Jonaitis EM, Allison SL, et al
    Amyloid and tau imaging biomarkers explain cognitive decline from late middle-age.
    Brain. 2020;143:320-335.
    PubMed     Abstract available


  130. ROWE J
    Editorial.
    Brain. 2020;143:1.
    PubMed    


    December 2019
  131. BADHWAR A, McFall GP, Sapkota S, Black SE, et al
    A multiomics approach to heterogeneity in Alzheimer's disease: focused review and roadmap.
    Brain. 2019 Dec 31. pii: 5692271. doi: 10.1093.
    PubMed     Abstract available


  132. GOURMAUD S, Shou H, Irwin DJ, Sansalone K, et al
    Alzheimer-like amyloid and tau alterations associated with cognitive deficit in temporal lobe epilepsy.
    Brain. 2019 Dec 13. pii: 5675543. doi: 10.1093.
    PubMed     Abstract available


  133. BLENNOW K, Chen C, Cicognola C, Wildsmith KR, et al
    Cerebrospinal fluid tau fragment correlates with tau PET: a candidate biomarker for tangle pathology.
    Brain. 2019 Dec 13. pii: 5675540. doi: 10.1093.
    PubMed     Abstract available


  134. KORONYO-HAMAOUI M, Sheyn J, Hayden EY, Li S, et al
    Peripherally derived angiotensin converting enzyme-enhanced macrophages alleviate Alzheimer-related disease.
    Brain. 2019 Dec 3. pii: 5651064. doi: 10.1093.
    PubMed     Abstract available


    November 2019
  135. MORRONE CD, Bazzigaluppi P, Beckett TL, Hill ME, et al
    Regional differences in Alzheimer's disease pathology confound behavioural rescue after amyloid-beta attenuation.
    Brain. 2019 Nov 28. pii: 5647334. doi: 10.1093.
    PubMed     Abstract available


  136. YOUNAN D, Petkus AJ, Widaman KF, Wang X, et al
    Particulate matter and episodic memory decline mediated by early neuroanatomic biomarkers of Alzheimer's disease.
    Brain. 2019 Nov 20. pii: 5628036. doi: 10.1093.
    PubMed     Abstract available


    October 2019
  137. LIU G, Zhang H, Liu B, Ji X, et al
    Rs2293871 regulates HTRA1 expression and affects cerebral small vessel stroke and Alzheimer's disease.
    Brain. 2019 Oct 11. pii: 5585665. doi: 10.1093.
    PubMed    


  138. ZHANG M, Dilliott AA, Khallaf R, Robinson JF, et al
    Genetic and epigenetic study of an Alzheimer's disease family with monozygotic triplets.
    Brain. 2019 Oct 3. pii: 5580538. doi: 10.1093.
    PubMed     Abstract available


    September 2019
  139. TAKAHATA K, Kimura Y, Sahara N, Koga S, et al
    PET-detectable tau pathology correlates with long-term neuropsychiatric outcomes in patients with traumatic brain injury.
    Brain. 2019 Sep 2. pii: 5556830. doi: 10.1093.
    PubMed     Abstract available


    June 2019
  140. JEGANATHAN J, Breakspear M
    Are the 'atoms of thought' longer in Lewy body dementia?
    Brain. 2019;142:1494-1497.
    PubMed    


  141. HOWETT D, Castegnaro A, Krzywicka K, Hagman J, et al
    Differentiation of mild cognitive impairment using an entorhinal cortex-based test of virtual reality navigation.
    Brain. 2019;142:1751-1766.
    PubMed     Abstract available


  142. NELSON PT, Dickson DW, Trojanowski JQ, Jack CR, et al
    Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report.
    Brain. 2019;142:1503-1527.
    PubMed     Abstract available


  143. ALBERT M, Mairet-Coello G, Danis C, Lieger S, et al
    Prevention of tau seeding and propagation by immunotherapy with a central tau epitope antibody.
    Brain. 2019;142:1736-1750.
    PubMed     Abstract available


  144. SCHUMACHER J, Peraza LR, Firbank M, Thomas AJ, et al
    Dysfunctional brain dynamics and their origin in Lewy body dementia.
    Brain. 2019;142:1767-1782.
    PubMed     Abstract available


    April 2019
  145. ILLAN-GALA I, Montal V, Borrego-Ecija S, Vilaplana E, et al
    Cortical microstructure in the behavioural variant of frontotemporal dementia: looking beyond atrophy.
    Brain. 2019;142:1121-1133.
    PubMed     Abstract available


  146. KNOPMAN DS, Lundt ES, Therneau TM, Vemuri P, et al
    Entorhinal cortex tau, amyloid-beta, cortical thickness and memory performance in non-demented subjects.
    Brain. 2019;142:1148-1160.
    PubMed     Abstract available


    January 2019
  147. POWER MC
    Growing evidence links air pollution exposure to risk of Alzheimer's disease and related dementia.
    Brain. 2019;143:8-10.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: